Related Experiment Videos
Cysteinyl leukotriene receptors.
1Department of Pharmacology, Center for Experimental Therapeutics, University of Pennsylvania, Philadelphia, PA 19014, USA.
Biochemical Pharmacology
|November 14, 2002
Summary
Cysteinyl leukotrienes (CysLTs) are key inflammatory mediators. This review details CysLT receptor cloning, expression, and signaling, advancing understanding of asthma and new CysLT functions.
Area of Science:
- Immunology
- Pharmacology
- Molecular Biology
Background:
- Cysteinyl leukotrienes (CysLTs) are critical inflammatory mediators implicated in asthma and allergic conditions.
- Two primary CysLT receptors, CysLT1 and CysLT2, mediate known CysLT biological actions.
- Regulation of CysLT receptor expression and signaling in disease remains poorly understood.
Purpose of the Study:
- To review the molecular cloning, ligand binding, expression, signaling, and functions of CysLT receptors.
- To bridge early pharmacological insights with future molecular-level investigations.
- To enhance understanding of CysLT receptor roles in disease pathogenesis.
Main Methods:
- Review of recent molecular cloning studies for CysLT receptor subtypes.
- Summary of pharmacological data on CysLT receptor sensitivity to antagonists.
- Compilation of expression data for CysLT1 and CysLT2 receptors in various tissues.
Main Results:
- Molecular cloning of both CysLT receptor subtypes facilitates future research.
- CysLT1 receptor expression is confirmed in lung tissues and peripheral blood cells.
- CysLT2 receptor has been detected in the heart, brain, and adrenal glands, suggesting novel functions.
Conclusions:
- Elucidating CysLT1 receptor's role in airway inflammation deepens understanding of asthma.
- The discovery of CysLT2 receptors in new locations sparks research into additional CysLT functions.
- This review provides a foundation for future molecular studies on CysLT receptor signal transduction.